Pycnogenol in People With Post-COVID-19 Condition: a Quadruple-blind, Randomized, Placebo-controlled Trial
Post COVID-19 Condition · Long COVID
Enrolment: 153 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Post COVID-19 Condition · Long COVID
Enrolment: 153 · Results not recorded
Varicose Veins
Enrolment: 338 · Results not recorded
ADHD
Enrolment: 32 · Results not recorded
Healthy
Enrolment: 14 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Three full-thickness excisional skin wounds of 1.3 cm by 1.3 cm by 2 mm per animal, in healthy rats and in rats made diabetic with a single dose of alloxan
Pycnogenol-treated wounds showed greater average size reduction at 58.03 per cent than untreated wounds at 45.73 per cent or cleanser and silver sulfadiazine treated wounds at 48.73 per cent, with higher collagen deposition and neovascularisation scores in diabetic rats.
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.